Human In Vitro 3D BioSPHEER™: A Unique Platform for Cancer & Immuno- Oncology Drug Evaluation
Time: 9:00 am
day: Conference Day Two
Details:
- Incorporating cancer and fibroblast cell lines into advanced human-derived 3D<i> in vitro</i> models with the option to include immune cells
- How can immune cells drive tumor cell killing <i>in vitro</i>?
- Learnings from studying mono- and combination-therapies of chemo agents, antibody-drug conjugates, and immunotherapies